Global HIV Diagnostics Market Research Report 2024(Status and Outlook)
Report Overview:
The HIV diagnostics market encompasses diagnostic screening and confirmatory tests for HIV-1, 2 and group O incidence testing. These tests have primary applications to screen and differentiate between the various groups and subtypes of human immunodeficiency virus.
The Global HIV Diagnostics Market Size was estimated at USD 2885.48 million in 2023 and is projected to reach USD 4707.57 million by 2029, exhibiting a CAGR of 8.50% during the forecast period.
This report provides a deep insight into the global HIV Diagnostics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global HIV Diagnostics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the HIV Diagnostics market in any manner.
Global HIV Diagnostics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbott
Abbott Healthcare
Abbvie Inc.
Brsitol-Myers Squibb
Janssen Therapeutics
Gilead Sciences
Merck & Co. Inc
VIIV Healthcare
BD Biosciences
Beckman Coulter
Partec
Sysmex
Apogee Flow Systems
PointCare Technologies Inc.
Zyomyx Inc.
Mylan inc.
Roche Diagnostics
Siemens Healthcare
Qiagen
BioMerieux
Market Segmentation (by Type)
Consumables
Assay, Kits and Reagents
Other Consumables
Instruments
Software and Services
Market Segmentation (by Application)
Antibody Tests
Viral Load Tests
CD4 Tests
Tests for Early Infant Diagnosis
Tests for Viral Identification
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the HIV Diagnostics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
The HIV diagnostics market encompasses diagnostic screening and confirmatory tests for HIV-1, 2 and group O incidence testing. These tests have primary applications to screen and differentiate between the various groups and subtypes of human immunodeficiency virus.
The Global HIV Diagnostics Market Size was estimated at USD 2885.48 million in 2023 and is projected to reach USD 4707.57 million by 2029, exhibiting a CAGR of 8.50% during the forecast period.
This report provides a deep insight into the global HIV Diagnostics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global HIV Diagnostics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the HIV Diagnostics market in any manner.
Global HIV Diagnostics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbott
Abbott Healthcare
Abbvie Inc.
Brsitol-Myers Squibb
Janssen Therapeutics
Gilead Sciences
Merck & Co. Inc
VIIV Healthcare
BD Biosciences
Beckman Coulter
Partec
Sysmex
Apogee Flow Systems
PointCare Technologies Inc.
Zyomyx Inc.
Mylan inc.
Roche Diagnostics
Siemens Healthcare
Qiagen
BioMerieux
Market Segmentation (by Type)
Consumables
Assay, Kits and Reagents
Other Consumables
Instruments
Software and Services
Market Segmentation (by Application)
Antibody Tests
Viral Load Tests
CD4 Tests
Tests for Early Infant Diagnosis
Tests for Viral Identification
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the HIV Diagnostics Market
- Overview of the regional outlook of the HIV Diagnostics Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the HIV Diagnostics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of HIV Diagnostics
1.2 Key Market Segments
1.2.1 HIV Diagnostics Segment by Type
1.2.2 HIV Diagnostics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HIV DIAGNOSTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global HIV Diagnostics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global HIV Diagnostics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HIV DIAGNOSTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global HIV Diagnostics Sales by Manufacturers (2019-2024)
3.2 Global HIV Diagnostics Revenue Market Share by Manufacturers (2019-2024)
3.3 HIV Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global HIV Diagnostics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers HIV Diagnostics Sales Sites, Area Served, Product Type
3.6 HIV Diagnostics Market Competitive Situation and Trends
3.6.1 HIV Diagnostics Market Concentration Rate
3.6.2 Global 5 and 10 Largest HIV Diagnostics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 HIV DIAGNOSTICS INDUSTRY CHAIN ANALYSIS
4.1 HIV Diagnostics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF HIV DIAGNOSTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 HIV DIAGNOSTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global HIV Diagnostics Sales Market Share by Type (2019-2024)
6.3 Global HIV Diagnostics Market Size Market Share by Type (2019-2024)
6.4 Global HIV Diagnostics Price by Type (2019-2024)
7 HIV DIAGNOSTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global HIV Diagnostics Market Sales by Application (2019-2024)
7.3 Global HIV Diagnostics Market Size (M USD) by Application (2019-2024)
7.4 Global HIV Diagnostics Sales Growth Rate by Application (2019-2024)
8 HIV DIAGNOSTICS MARKET SEGMENTATION BY REGION
8.1 Global HIV Diagnostics Sales by Region
8.1.1 Global HIV Diagnostics Sales by Region
8.1.2 Global HIV Diagnostics Sales Market Share by Region
8.2 North America
8.2.1 North America HIV Diagnostics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe HIV Diagnostics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific HIV Diagnostics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America HIV Diagnostics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa HIV Diagnostics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Abbott
9.1.1 Abbott HIV Diagnostics Basic Information
9.1.2 Abbott HIV Diagnostics Product Overview
9.1.3 Abbott HIV Diagnostics Product Market Performance
9.1.4 Abbott Business Overview
9.1.5 Abbott HIV Diagnostics SWOT Analysis
9.1.6 Abbott Recent Developments
9.2 Abbott Healthcare
9.2.1 Abbott Healthcare HIV Diagnostics Basic Information
9.2.2 Abbott Healthcare HIV Diagnostics Product Overview
9.2.3 Abbott Healthcare HIV Diagnostics Product Market Performance
9.2.4 Abbott Healthcare Business Overview
9.2.5 Abbott Healthcare HIV Diagnostics SWOT Analysis
9.2.6 Abbott Healthcare Recent Developments
9.3 Abbvie Inc.
9.3.1 Abbvie Inc. HIV Diagnostics Basic Information
9.3.2 Abbvie Inc. HIV Diagnostics Product Overview
9.3.3 Abbvie Inc. HIV Diagnostics Product Market Performance
9.3.4 Abbvie Inc. HIV Diagnostics SWOT Analysis
9.3.5 Abbvie Inc. Business Overview
9.3.6 Abbvie Inc. Recent Developments
9.4 Brsitol-Myers Squibb
9.4.1 Brsitol-Myers Squibb HIV Diagnostics Basic Information
9.4.2 Brsitol-Myers Squibb HIV Diagnostics Product Overview
9.4.3 Brsitol-Myers Squibb HIV Diagnostics Product Market Performance
9.4.4 Brsitol-Myers Squibb Business Overview
9.4.5 Brsitol-Myers Squibb Recent Developments
9.5 Janssen Therapeutics
9.5.1 Janssen Therapeutics HIV Diagnostics Basic Information
9.5.2 Janssen Therapeutics HIV Diagnostics Product Overview
9.5.3 Janssen Therapeutics HIV Diagnostics Product Market Performance
9.5.4 Janssen Therapeutics Business Overview
9.5.5 Janssen Therapeutics Recent Developments
9.6 Gilead Sciences
9.6.1 Gilead Sciences HIV Diagnostics Basic Information
9.6.2 Gilead Sciences HIV Diagnostics Product Overview
9.6.3 Gilead Sciences HIV Diagnostics Product Market Performance
9.6.4 Gilead Sciences Business Overview
9.6.5 Gilead Sciences Recent Developments
9.7 Merck and Co. Inc
9.7.1 Merck and Co. Inc HIV Diagnostics Basic Information
9.7.2 Merck and Co. Inc HIV Diagnostics Product Overview
9.7.3 Merck and Co. Inc HIV Diagnostics Product Market Performance
9.7.4 Merck and Co. Inc Business Overview
9.7.5 Merck and Co. Inc Recent Developments
9.8 VIIV Healthcare
9.8.1 VIIV Healthcare HIV Diagnostics Basic Information
9.8.2 VIIV Healthcare HIV Diagnostics Product Overview
9.8.3 VIIV Healthcare HIV Diagnostics Product Market Performance
9.8.4 VIIV Healthcare Business Overview
9.8.5 VIIV Healthcare Recent Developments
9.9 BD Biosciences
9.9.1 BD Biosciences HIV Diagnostics Basic Information
9.9.2 BD Biosciences HIV Diagnostics Product Overview
9.9.3 BD Biosciences HIV Diagnostics Product Market Performance
9.9.4 BD Biosciences Business Overview
9.9.5 BD Biosciences Recent Developments
9.10 Beckman Coulter
9.10.1 Beckman Coulter HIV Diagnostics Basic Information
9.10.2 Beckman Coulter HIV Diagnostics Product Overview
9.10.3 Beckman Coulter HIV Diagnostics Product Market Performance
9.10.4 Beckman Coulter Business Overview
9.10.5 Beckman Coulter Recent Developments
9.11 Partec
9.11.1 Partec HIV Diagnostics Basic Information
9.11.2 Partec HIV Diagnostics Product Overview
9.11.3 Partec HIV Diagnostics Product Market Performance
9.11.4 Partec Business Overview
9.11.5 Partec Recent Developments
9.12 Sysmex
9.12.1 Sysmex HIV Diagnostics Basic Information
9.12.2 Sysmex HIV Diagnostics Product Overview
9.12.3 Sysmex HIV Diagnostics Product Market Performance
9.12.4 Sysmex Business Overview
9.12.5 Sysmex Recent Developments
9.13 Apogee Flow Systems
9.13.1 Apogee Flow Systems HIV Diagnostics Basic Information
9.13.2 Apogee Flow Systems HIV Diagnostics Product Overview
9.13.3 Apogee Flow Systems HIV Diagnostics Product Market Performance
9.13.4 Apogee Flow Systems Business Overview
9.13.5 Apogee Flow Systems Recent Developments
9.14 PointCare Technologies Inc.
9.14.1 PointCare Technologies Inc. HIV Diagnostics Basic Information
9.14.2 PointCare Technologies Inc. HIV Diagnostics Product Overview
9.14.3 PointCare Technologies Inc. HIV Diagnostics Product Market Performance
9.14.4 PointCare Technologies Inc. Business Overview
9.14.5 PointCare Technologies Inc. Recent Developments
9.15 Zyomyx Inc.
9.15.1 Zyomyx Inc. HIV Diagnostics Basic Information
9.15.2 Zyomyx Inc. HIV Diagnostics Product Overview
9.15.3 Zyomyx Inc. HIV Diagnostics Product Market Performance
9.15.4 Zyomyx Inc. Business Overview
9.15.5 Zyomyx Inc. Recent Developments
9.16 Mylan inc.
9.16.1 Mylan inc. HIV Diagnostics Basic Information
9.16.2 Mylan inc. HIV Diagnostics Product Overview
9.16.3 Mylan inc. HIV Diagnostics Product Market Performance
9.16.4 Mylan inc. Business Overview
9.16.5 Mylan inc. Recent Developments
9.17 Roche Diagnostics
9.17.1 Roche Diagnostics HIV Diagnostics Basic Information
9.17.2 Roche Diagnostics HIV Diagnostics Product Overview
9.17.3 Roche Diagnostics HIV Diagnostics Product Market Performance
9.17.4 Roche Diagnostics Business Overview
9.17.5 Roche Diagnostics Recent Developments
9.18 Siemens Healthcare
9.18.1 Siemens Healthcare HIV Diagnostics Basic Information
9.18.2 Siemens Healthcare HIV Diagnostics Product Overview
9.18.3 Siemens Healthcare HIV Diagnostics Product Market Performance
9.18.4 Siemens Healthcare Business Overview
9.18.5 Siemens Healthcare Recent Developments
9.19 Qiagen
9.19.1 Qiagen HIV Diagnostics Basic Information
9.19.2 Qiagen HIV Diagnostics Product Overview
9.19.3 Qiagen HIV Diagnostics Product Market Performance
9.19.4 Qiagen Business Overview
9.19.5 Qiagen Recent Developments
9.20 BioMerieux
9.20.1 BioMerieux HIV Diagnostics Basic Information
9.20.2 BioMerieux HIV Diagnostics Product Overview
9.20.3 BioMerieux HIV Diagnostics Product Market Performance
9.20.4 BioMerieux Business Overview
9.20.5 BioMerieux Recent Developments
10 HIV DIAGNOSTICS MARKET FORECAST BY REGION
10.1 Global HIV Diagnostics Market Size Forecast
10.2 Global HIV Diagnostics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe HIV Diagnostics Market Size Forecast by Country
10.2.3 Asia Pacific HIV Diagnostics Market Size Forecast by Region
10.2.4 South America HIV Diagnostics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of HIV Diagnostics by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global HIV Diagnostics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of HIV Diagnostics by Type (2025-2030)
11.1.2 Global HIV Diagnostics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of HIV Diagnostics by Type (2025-2030)
11.2 Global HIV Diagnostics Market Forecast by Application (2025-2030)
11.2.1 Global HIV Diagnostics Sales (K Units) Forecast by Application
11.2.2 Global HIV Diagnostics Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of HIV Diagnostics
1.2 Key Market Segments
1.2.1 HIV Diagnostics Segment by Type
1.2.2 HIV Diagnostics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HIV DIAGNOSTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global HIV Diagnostics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global HIV Diagnostics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HIV DIAGNOSTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global HIV Diagnostics Sales by Manufacturers (2019-2024)
3.2 Global HIV Diagnostics Revenue Market Share by Manufacturers (2019-2024)
3.3 HIV Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global HIV Diagnostics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers HIV Diagnostics Sales Sites, Area Served, Product Type
3.6 HIV Diagnostics Market Competitive Situation and Trends
3.6.1 HIV Diagnostics Market Concentration Rate
3.6.2 Global 5 and 10 Largest HIV Diagnostics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 HIV DIAGNOSTICS INDUSTRY CHAIN ANALYSIS
4.1 HIV Diagnostics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF HIV DIAGNOSTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 HIV DIAGNOSTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global HIV Diagnostics Sales Market Share by Type (2019-2024)
6.3 Global HIV Diagnostics Market Size Market Share by Type (2019-2024)
6.4 Global HIV Diagnostics Price by Type (2019-2024)
7 HIV DIAGNOSTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global HIV Diagnostics Market Sales by Application (2019-2024)
7.3 Global HIV Diagnostics Market Size (M USD) by Application (2019-2024)
7.4 Global HIV Diagnostics Sales Growth Rate by Application (2019-2024)
8 HIV DIAGNOSTICS MARKET SEGMENTATION BY REGION
8.1 Global HIV Diagnostics Sales by Region
8.1.1 Global HIV Diagnostics Sales by Region
8.1.2 Global HIV Diagnostics Sales Market Share by Region
8.2 North America
8.2.1 North America HIV Diagnostics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe HIV Diagnostics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific HIV Diagnostics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America HIV Diagnostics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa HIV Diagnostics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Abbott
9.1.1 Abbott HIV Diagnostics Basic Information
9.1.2 Abbott HIV Diagnostics Product Overview
9.1.3 Abbott HIV Diagnostics Product Market Performance
9.1.4 Abbott Business Overview
9.1.5 Abbott HIV Diagnostics SWOT Analysis
9.1.6 Abbott Recent Developments
9.2 Abbott Healthcare
9.2.1 Abbott Healthcare HIV Diagnostics Basic Information
9.2.2 Abbott Healthcare HIV Diagnostics Product Overview
9.2.3 Abbott Healthcare HIV Diagnostics Product Market Performance
9.2.4 Abbott Healthcare Business Overview
9.2.5 Abbott Healthcare HIV Diagnostics SWOT Analysis
9.2.6 Abbott Healthcare Recent Developments
9.3 Abbvie Inc.
9.3.1 Abbvie Inc. HIV Diagnostics Basic Information
9.3.2 Abbvie Inc. HIV Diagnostics Product Overview
9.3.3 Abbvie Inc. HIV Diagnostics Product Market Performance
9.3.4 Abbvie Inc. HIV Diagnostics SWOT Analysis
9.3.5 Abbvie Inc. Business Overview
9.3.6 Abbvie Inc. Recent Developments
9.4 Brsitol-Myers Squibb
9.4.1 Brsitol-Myers Squibb HIV Diagnostics Basic Information
9.4.2 Brsitol-Myers Squibb HIV Diagnostics Product Overview
9.4.3 Brsitol-Myers Squibb HIV Diagnostics Product Market Performance
9.4.4 Brsitol-Myers Squibb Business Overview
9.4.5 Brsitol-Myers Squibb Recent Developments
9.5 Janssen Therapeutics
9.5.1 Janssen Therapeutics HIV Diagnostics Basic Information
9.5.2 Janssen Therapeutics HIV Diagnostics Product Overview
9.5.3 Janssen Therapeutics HIV Diagnostics Product Market Performance
9.5.4 Janssen Therapeutics Business Overview
9.5.5 Janssen Therapeutics Recent Developments
9.6 Gilead Sciences
9.6.1 Gilead Sciences HIV Diagnostics Basic Information
9.6.2 Gilead Sciences HIV Diagnostics Product Overview
9.6.3 Gilead Sciences HIV Diagnostics Product Market Performance
9.6.4 Gilead Sciences Business Overview
9.6.5 Gilead Sciences Recent Developments
9.7 Merck and Co. Inc
9.7.1 Merck and Co. Inc HIV Diagnostics Basic Information
9.7.2 Merck and Co. Inc HIV Diagnostics Product Overview
9.7.3 Merck and Co. Inc HIV Diagnostics Product Market Performance
9.7.4 Merck and Co. Inc Business Overview
9.7.5 Merck and Co. Inc Recent Developments
9.8 VIIV Healthcare
9.8.1 VIIV Healthcare HIV Diagnostics Basic Information
9.8.2 VIIV Healthcare HIV Diagnostics Product Overview
9.8.3 VIIV Healthcare HIV Diagnostics Product Market Performance
9.8.4 VIIV Healthcare Business Overview
9.8.5 VIIV Healthcare Recent Developments
9.9 BD Biosciences
9.9.1 BD Biosciences HIV Diagnostics Basic Information
9.9.2 BD Biosciences HIV Diagnostics Product Overview
9.9.3 BD Biosciences HIV Diagnostics Product Market Performance
9.9.4 BD Biosciences Business Overview
9.9.5 BD Biosciences Recent Developments
9.10 Beckman Coulter
9.10.1 Beckman Coulter HIV Diagnostics Basic Information
9.10.2 Beckman Coulter HIV Diagnostics Product Overview
9.10.3 Beckman Coulter HIV Diagnostics Product Market Performance
9.10.4 Beckman Coulter Business Overview
9.10.5 Beckman Coulter Recent Developments
9.11 Partec
9.11.1 Partec HIV Diagnostics Basic Information
9.11.2 Partec HIV Diagnostics Product Overview
9.11.3 Partec HIV Diagnostics Product Market Performance
9.11.4 Partec Business Overview
9.11.5 Partec Recent Developments
9.12 Sysmex
9.12.1 Sysmex HIV Diagnostics Basic Information
9.12.2 Sysmex HIV Diagnostics Product Overview
9.12.3 Sysmex HIV Diagnostics Product Market Performance
9.12.4 Sysmex Business Overview
9.12.5 Sysmex Recent Developments
9.13 Apogee Flow Systems
9.13.1 Apogee Flow Systems HIV Diagnostics Basic Information
9.13.2 Apogee Flow Systems HIV Diagnostics Product Overview
9.13.3 Apogee Flow Systems HIV Diagnostics Product Market Performance
9.13.4 Apogee Flow Systems Business Overview
9.13.5 Apogee Flow Systems Recent Developments
9.14 PointCare Technologies Inc.
9.14.1 PointCare Technologies Inc. HIV Diagnostics Basic Information
9.14.2 PointCare Technologies Inc. HIV Diagnostics Product Overview
9.14.3 PointCare Technologies Inc. HIV Diagnostics Product Market Performance
9.14.4 PointCare Technologies Inc. Business Overview
9.14.5 PointCare Technologies Inc. Recent Developments
9.15 Zyomyx Inc.
9.15.1 Zyomyx Inc. HIV Diagnostics Basic Information
9.15.2 Zyomyx Inc. HIV Diagnostics Product Overview
9.15.3 Zyomyx Inc. HIV Diagnostics Product Market Performance
9.15.4 Zyomyx Inc. Business Overview
9.15.5 Zyomyx Inc. Recent Developments
9.16 Mylan inc.
9.16.1 Mylan inc. HIV Diagnostics Basic Information
9.16.2 Mylan inc. HIV Diagnostics Product Overview
9.16.3 Mylan inc. HIV Diagnostics Product Market Performance
9.16.4 Mylan inc. Business Overview
9.16.5 Mylan inc. Recent Developments
9.17 Roche Diagnostics
9.17.1 Roche Diagnostics HIV Diagnostics Basic Information
9.17.2 Roche Diagnostics HIV Diagnostics Product Overview
9.17.3 Roche Diagnostics HIV Diagnostics Product Market Performance
9.17.4 Roche Diagnostics Business Overview
9.17.5 Roche Diagnostics Recent Developments
9.18 Siemens Healthcare
9.18.1 Siemens Healthcare HIV Diagnostics Basic Information
9.18.2 Siemens Healthcare HIV Diagnostics Product Overview
9.18.3 Siemens Healthcare HIV Diagnostics Product Market Performance
9.18.4 Siemens Healthcare Business Overview
9.18.5 Siemens Healthcare Recent Developments
9.19 Qiagen
9.19.1 Qiagen HIV Diagnostics Basic Information
9.19.2 Qiagen HIV Diagnostics Product Overview
9.19.3 Qiagen HIV Diagnostics Product Market Performance
9.19.4 Qiagen Business Overview
9.19.5 Qiagen Recent Developments
9.20 BioMerieux
9.20.1 BioMerieux HIV Diagnostics Basic Information
9.20.2 BioMerieux HIV Diagnostics Product Overview
9.20.3 BioMerieux HIV Diagnostics Product Market Performance
9.20.4 BioMerieux Business Overview
9.20.5 BioMerieux Recent Developments
10 HIV DIAGNOSTICS MARKET FORECAST BY REGION
10.1 Global HIV Diagnostics Market Size Forecast
10.2 Global HIV Diagnostics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe HIV Diagnostics Market Size Forecast by Country
10.2.3 Asia Pacific HIV Diagnostics Market Size Forecast by Region
10.2.4 South America HIV Diagnostics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of HIV Diagnostics by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global HIV Diagnostics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of HIV Diagnostics by Type (2025-2030)
11.1.2 Global HIV Diagnostics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of HIV Diagnostics by Type (2025-2030)
11.2 Global HIV Diagnostics Market Forecast by Application (2025-2030)
11.2.1 Global HIV Diagnostics Sales (K Units) Forecast by Application
11.2.2 Global HIV Diagnostics Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. HIV Diagnostics Market Size Comparison by Region (M USD)
Table 5. Global HIV Diagnostics Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global HIV Diagnostics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global HIV Diagnostics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global HIV Diagnostics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV Diagnostics as of 2022)
Table 10. Global Market HIV Diagnostics Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers HIV Diagnostics Sales Sites and Area Served
Table 12. Manufacturers HIV Diagnostics Product Type
Table 13. Global HIV Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of HIV Diagnostics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. HIV Diagnostics Market Challenges
Table 22. Global HIV Diagnostics Sales by Type (K Units)
Table 23. Global HIV Diagnostics Market Size by Type (M USD)
Table 24. Global HIV Diagnostics Sales (K Units) by Type (2019-2024)
Table 25. Global HIV Diagnostics Sales Market Share by Type (2019-2024)
Table 26. Global HIV Diagnostics Market Size (M USD) by Type (2019-2024)
Table 27. Global HIV Diagnostics Market Size Share by Type (2019-2024)
Table 28. Global HIV Diagnostics Price (USD/Unit) by Type (2019-2024)
Table 29. Global HIV Diagnostics Sales (K Units) by Application
Table 30. Global HIV Diagnostics Market Size by Application
Table 31. Global HIV Diagnostics Sales by Application (2019-2024) & (K Units)
Table 32. Global HIV Diagnostics Sales Market Share by Application (2019-2024)
Table 33. Global HIV Diagnostics Sales by Application (2019-2024) & (M USD)
Table 34. Global HIV Diagnostics Market Share by Application (2019-2024)
Table 35. Global HIV Diagnostics Sales Growth Rate by Application (2019-2024)
Table 36. Global HIV Diagnostics Sales by Region (2019-2024) & (K Units)
Table 37. Global HIV Diagnostics Sales Market Share by Region (2019-2024)
Table 38. North America HIV Diagnostics Sales by Country (2019-2024) & (K Units)
Table 39. Europe HIV Diagnostics Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific HIV Diagnostics Sales by Region (2019-2024) & (K Units)
Table 41. South America HIV Diagnostics Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa HIV Diagnostics Sales by Region (2019-2024) & (K Units)
Table 43. Abbott HIV Diagnostics Basic Information
Table 44. Abbott HIV Diagnostics Product Overview
Table 45. Abbott HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Abbott Business Overview
Table 47. Abbott HIV Diagnostics SWOT Analysis
Table 48. Abbott Recent Developments
Table 49. Abbott Healthcare HIV Diagnostics Basic Information
Table 50. Abbott Healthcare HIV Diagnostics Product Overview
Table 51. Abbott Healthcare HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Abbott Healthcare Business Overview
Table 53. Abbott Healthcare HIV Diagnostics SWOT Analysis
Table 54. Abbott Healthcare Recent Developments
Table 55. Abbvie Inc. HIV Diagnostics Basic Information
Table 56. Abbvie Inc. HIV Diagnostics Product Overview
Table 57. Abbvie Inc. HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Abbvie Inc. HIV Diagnostics SWOT Analysis
Table 59. Abbvie Inc. Business Overview
Table 60. Abbvie Inc. Recent Developments
Table 61. Brsitol-Myers Squibb HIV Diagnostics Basic Information
Table 62. Brsitol-Myers Squibb HIV Diagnostics Product Overview
Table 63. Brsitol-Myers Squibb HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Brsitol-Myers Squibb Business Overview
Table 65. Brsitol-Myers Squibb Recent Developments
Table 66. Janssen Therapeutics HIV Diagnostics Basic Information
Table 67. Janssen Therapeutics HIV Diagnostics Product Overview
Table 68. Janssen Therapeutics HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Janssen Therapeutics Business Overview
Table 70. Janssen Therapeutics Recent Developments
Table 71. Gilead Sciences HIV Diagnostics Basic Information
Table 72. Gilead Sciences HIV Diagnostics Product Overview
Table 73. Gilead Sciences HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Gilead Sciences Business Overview
Table 75. Gilead Sciences Recent Developments
Table 76. Merck and Co. Inc HIV Diagnostics Basic Information
Table 77. Merck and Co. Inc HIV Diagnostics Product Overview
Table 78. Merck and Co. Inc HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Merck and Co. Inc Business Overview
Table 80. Merck and Co. Inc Recent Developments
Table 81. VIIV Healthcare HIV Diagnostics Basic Information
Table 82. VIIV Healthcare HIV Diagnostics Product Overview
Table 83. VIIV Healthcare HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. VIIV Healthcare Business Overview
Table 85. VIIV Healthcare Recent Developments
Table 86. BD Biosciences HIV Diagnostics Basic Information
Table 87. BD Biosciences HIV Diagnostics Product Overview
Table 88. BD Biosciences HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. BD Biosciences Business Overview
Table 90. BD Biosciences Recent Developments
Table 91. Beckman Coulter HIV Diagnostics Basic Information
Table 92. Beckman Coulter HIV Diagnostics Product Overview
Table 93. Beckman Coulter HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Beckman Coulter Business Overview
Table 95. Beckman Coulter Recent Developments
Table 96. Partec HIV Diagnostics Basic Information
Table 97. Partec HIV Diagnostics Product Overview
Table 98. Partec HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Partec Business Overview
Table 100. Partec Recent Developments
Table 101. Sysmex HIV Diagnostics Basic Information
Table 102. Sysmex HIV Diagnostics Product Overview
Table 103. Sysmex HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Sysmex Business Overview
Table 105. Sysmex Recent Developments
Table 106. Apogee Flow Systems HIV Diagnostics Basic Information
Table 107. Apogee Flow Systems HIV Diagnostics Product Overview
Table 108. Apogee Flow Systems HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Apogee Flow Systems Business Overview
Table 110. Apogee Flow Systems Recent Developments
Table 111. PointCare Technologies Inc. HIV Diagnostics Basic Information
Table 112. PointCare Technologies Inc. HIV Diagnostics Product Overview
Table 113. PointCare Technologies Inc. HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. PointCare Technologies Inc. Business Overview
Table 115. PointCare Technologies Inc. Recent Developments
Table 116. Zyomyx Inc. HIV Diagnostics Basic Information
Table 117. Zyomyx Inc. HIV Diagnostics Product Overview
Table 118. Zyomyx Inc. HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Zyomyx Inc. Business Overview
Table 120. Zyomyx Inc. Recent Developments
Table 121. Mylan inc. HIV Diagnostics Basic Information
Table 122. Mylan inc. HIV Diagnostics Product Overview
Table 123. Mylan inc. HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Mylan inc. Business Overview
Table 125. Mylan inc. Recent Developments
Table 126. Roche Diagnostics HIV Diagnostics Basic Information
Table 127. Roche Diagnostics HIV Diagnostics Product Overview
Table 128. Roche Diagnostics HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Roche Diagnostics Business Overview
Table 130. Roche Diagnostics Recent Developments
Table 131. Siemens Healthcare HIV Diagnostics Basic Information
Table 132. Siemens Healthcare HIV Diagnostics Product Overview
Table 133. Siemens Healthcare HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Siemens Healthcare Business Overview
Table 135. Siemens Healthcare Recent Developments
Table 136. Qiagen HIV Diagnostics Basic Information
Table 137. Qiagen HIV Diagnostics Product Overview
Table 138. Qiagen HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. Qiagen Business Overview
Table 140. Qiagen Recent Developments
Table 141. BioMerieux HIV Diagnostics Basic Information
Table 142. BioMerieux HIV Diagnostics Product Overview
Table 143. BioMerieux HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. BioMerieux Business Overview
Table 145. BioMerieux Recent Developments
Table 146. Global HIV Diagnostics Sales Forecast by Region (2025-2030) & (K Units)
Table 147. Global HIV Diagnostics Market Size Forecast by Region (2025-2030) & (M USD)
Table 148. North America HIV Diagnostics Sales Forecast by Country (2025-2030) & (K Units)
Table 149. North America HIV Diagnostics Market Size Forecast by Country (2025-2030) & (M USD)
Table 150. Europe HIV Diagnostics Sales Forecast by Country (2025-2030) & (K Units)
Table 151. Europe HIV Diagnostics Market Size Forecast by Country (2025-2030) & (M USD)
Table 152. Asia Pacific HIV Diagnostics Sales Forecast by Region (2025-2030) & (K Units)
Table 153. Asia Pacific HIV Diagnostics Market Size Forecast by Region (2025-2030) & (M USD)
Table 154. South America HIV Diagnostics Sales Forecast by Country (2025-2030) & (K Units)
Table 155. South America HIV Diagnostics Market Size Forecast by Country (2025-2030) & (M USD)
Table 156. Middle East and Africa HIV Diagnostics Consumption Forecast by Country (2025-2030) & (Units)
Table 157. Middle East and Africa HIV Diagnostics Market Size Forecast by Country (2025-2030) & (M USD)
Table 158. Global HIV Diagnostics Sales Forecast by Type (2025-2030) & (K Units)
Table 159. Global HIV Diagnostics Market Size Forecast by Type (2025-2030) & (M USD)
Table 160. Global HIV Diagnostics Price Forecast by Type (2025-2030) & (USD/Unit)
Table 161. Global HIV Diagnostics Sales (K Units) Forecast by Application (2025-2030)
Table 162. Global HIV Diagnostics Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. HIV Diagnostics Market Size Comparison by Region (M USD)
Table 5. Global HIV Diagnostics Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global HIV Diagnostics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global HIV Diagnostics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global HIV Diagnostics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV Diagnostics as of 2022)
Table 10. Global Market HIV Diagnostics Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers HIV Diagnostics Sales Sites and Area Served
Table 12. Manufacturers HIV Diagnostics Product Type
Table 13. Global HIV Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of HIV Diagnostics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. HIV Diagnostics Market Challenges
Table 22. Global HIV Diagnostics Sales by Type (K Units)
Table 23. Global HIV Diagnostics Market Size by Type (M USD)
Table 24. Global HIV Diagnostics Sales (K Units) by Type (2019-2024)
Table 25. Global HIV Diagnostics Sales Market Share by Type (2019-2024)
Table 26. Global HIV Diagnostics Market Size (M USD) by Type (2019-2024)
Table 27. Global HIV Diagnostics Market Size Share by Type (2019-2024)
Table 28. Global HIV Diagnostics Price (USD/Unit) by Type (2019-2024)
Table 29. Global HIV Diagnostics Sales (K Units) by Application
Table 30. Global HIV Diagnostics Market Size by Application
Table 31. Global HIV Diagnostics Sales by Application (2019-2024) & (K Units)
Table 32. Global HIV Diagnostics Sales Market Share by Application (2019-2024)
Table 33. Global HIV Diagnostics Sales by Application (2019-2024) & (M USD)
Table 34. Global HIV Diagnostics Market Share by Application (2019-2024)
Table 35. Global HIV Diagnostics Sales Growth Rate by Application (2019-2024)
Table 36. Global HIV Diagnostics Sales by Region (2019-2024) & (K Units)
Table 37. Global HIV Diagnostics Sales Market Share by Region (2019-2024)
Table 38. North America HIV Diagnostics Sales by Country (2019-2024) & (K Units)
Table 39. Europe HIV Diagnostics Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific HIV Diagnostics Sales by Region (2019-2024) & (K Units)
Table 41. South America HIV Diagnostics Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa HIV Diagnostics Sales by Region (2019-2024) & (K Units)
Table 43. Abbott HIV Diagnostics Basic Information
Table 44. Abbott HIV Diagnostics Product Overview
Table 45. Abbott HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Abbott Business Overview
Table 47. Abbott HIV Diagnostics SWOT Analysis
Table 48. Abbott Recent Developments
Table 49. Abbott Healthcare HIV Diagnostics Basic Information
Table 50. Abbott Healthcare HIV Diagnostics Product Overview
Table 51. Abbott Healthcare HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Abbott Healthcare Business Overview
Table 53. Abbott Healthcare HIV Diagnostics SWOT Analysis
Table 54. Abbott Healthcare Recent Developments
Table 55. Abbvie Inc. HIV Diagnostics Basic Information
Table 56. Abbvie Inc. HIV Diagnostics Product Overview
Table 57. Abbvie Inc. HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Abbvie Inc. HIV Diagnostics SWOT Analysis
Table 59. Abbvie Inc. Business Overview
Table 60. Abbvie Inc. Recent Developments
Table 61. Brsitol-Myers Squibb HIV Diagnostics Basic Information
Table 62. Brsitol-Myers Squibb HIV Diagnostics Product Overview
Table 63. Brsitol-Myers Squibb HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Brsitol-Myers Squibb Business Overview
Table 65. Brsitol-Myers Squibb Recent Developments
Table 66. Janssen Therapeutics HIV Diagnostics Basic Information
Table 67. Janssen Therapeutics HIV Diagnostics Product Overview
Table 68. Janssen Therapeutics HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Janssen Therapeutics Business Overview
Table 70. Janssen Therapeutics Recent Developments
Table 71. Gilead Sciences HIV Diagnostics Basic Information
Table 72. Gilead Sciences HIV Diagnostics Product Overview
Table 73. Gilead Sciences HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Gilead Sciences Business Overview
Table 75. Gilead Sciences Recent Developments
Table 76. Merck and Co. Inc HIV Diagnostics Basic Information
Table 77. Merck and Co. Inc HIV Diagnostics Product Overview
Table 78. Merck and Co. Inc HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Merck and Co. Inc Business Overview
Table 80. Merck and Co. Inc Recent Developments
Table 81. VIIV Healthcare HIV Diagnostics Basic Information
Table 82. VIIV Healthcare HIV Diagnostics Product Overview
Table 83. VIIV Healthcare HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. VIIV Healthcare Business Overview
Table 85. VIIV Healthcare Recent Developments
Table 86. BD Biosciences HIV Diagnostics Basic Information
Table 87. BD Biosciences HIV Diagnostics Product Overview
Table 88. BD Biosciences HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. BD Biosciences Business Overview
Table 90. BD Biosciences Recent Developments
Table 91. Beckman Coulter HIV Diagnostics Basic Information
Table 92. Beckman Coulter HIV Diagnostics Product Overview
Table 93. Beckman Coulter HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Beckman Coulter Business Overview
Table 95. Beckman Coulter Recent Developments
Table 96. Partec HIV Diagnostics Basic Information
Table 97. Partec HIV Diagnostics Product Overview
Table 98. Partec HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Partec Business Overview
Table 100. Partec Recent Developments
Table 101. Sysmex HIV Diagnostics Basic Information
Table 102. Sysmex HIV Diagnostics Product Overview
Table 103. Sysmex HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Sysmex Business Overview
Table 105. Sysmex Recent Developments
Table 106. Apogee Flow Systems HIV Diagnostics Basic Information
Table 107. Apogee Flow Systems HIV Diagnostics Product Overview
Table 108. Apogee Flow Systems HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Apogee Flow Systems Business Overview
Table 110. Apogee Flow Systems Recent Developments
Table 111. PointCare Technologies Inc. HIV Diagnostics Basic Information
Table 112. PointCare Technologies Inc. HIV Diagnostics Product Overview
Table 113. PointCare Technologies Inc. HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. PointCare Technologies Inc. Business Overview
Table 115. PointCare Technologies Inc. Recent Developments
Table 116. Zyomyx Inc. HIV Diagnostics Basic Information
Table 117. Zyomyx Inc. HIV Diagnostics Product Overview
Table 118. Zyomyx Inc. HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Zyomyx Inc. Business Overview
Table 120. Zyomyx Inc. Recent Developments
Table 121. Mylan inc. HIV Diagnostics Basic Information
Table 122. Mylan inc. HIV Diagnostics Product Overview
Table 123. Mylan inc. HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Mylan inc. Business Overview
Table 125. Mylan inc. Recent Developments
Table 126. Roche Diagnostics HIV Diagnostics Basic Information
Table 127. Roche Diagnostics HIV Diagnostics Product Overview
Table 128. Roche Diagnostics HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Roche Diagnostics Business Overview
Table 130. Roche Diagnostics Recent Developments
Table 131. Siemens Healthcare HIV Diagnostics Basic Information
Table 132. Siemens Healthcare HIV Diagnostics Product Overview
Table 133. Siemens Healthcare HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Siemens Healthcare Business Overview
Table 135. Siemens Healthcare Recent Developments
Table 136. Qiagen HIV Diagnostics Basic Information
Table 137. Qiagen HIV Diagnostics Product Overview
Table 138. Qiagen HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. Qiagen Business Overview
Table 140. Qiagen Recent Developments
Table 141. BioMerieux HIV Diagnostics Basic Information
Table 142. BioMerieux HIV Diagnostics Product Overview
Table 143. BioMerieux HIV Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. BioMerieux Business Overview
Table 145. BioMerieux Recent Developments
Table 146. Global HIV Diagnostics Sales Forecast by Region (2025-2030) & (K Units)
Table 147. Global HIV Diagnostics Market Size Forecast by Region (2025-2030) & (M USD)
Table 148. North America HIV Diagnostics Sales Forecast by Country (2025-2030) & (K Units)
Table 149. North America HIV Diagnostics Market Size Forecast by Country (2025-2030) & (M USD)
Table 150. Europe HIV Diagnostics Sales Forecast by Country (2025-2030) & (K Units)
Table 151. Europe HIV Diagnostics Market Size Forecast by Country (2025-2030) & (M USD)
Table 152. Asia Pacific HIV Diagnostics Sales Forecast by Region (2025-2030) & (K Units)
Table 153. Asia Pacific HIV Diagnostics Market Size Forecast by Region (2025-2030) & (M USD)
Table 154. South America HIV Diagnostics Sales Forecast by Country (2025-2030) & (K Units)
Table 155. South America HIV Diagnostics Market Size Forecast by Country (2025-2030) & (M USD)
Table 156. Middle East and Africa HIV Diagnostics Consumption Forecast by Country (2025-2030) & (Units)
Table 157. Middle East and Africa HIV Diagnostics Market Size Forecast by Country (2025-2030) & (M USD)
Table 158. Global HIV Diagnostics Sales Forecast by Type (2025-2030) & (K Units)
Table 159. Global HIV Diagnostics Market Size Forecast by Type (2025-2030) & (M USD)
Table 160. Global HIV Diagnostics Price Forecast by Type (2025-2030) & (USD/Unit)
Table 161. Global HIV Diagnostics Sales (K Units) Forecast by Application (2025-2030)
Table 162. Global HIV Diagnostics Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of HIV Diagnostics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global HIV Diagnostics Market Size (M USD), 2019-2030
Figure 5. Global HIV Diagnostics Market Size (M USD) (2019-2030)
Figure 6. Global HIV Diagnostics Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. HIV Diagnostics Market Size by Country (M USD)
Figure 11. HIV Diagnostics Sales Share by Manufacturers in 2023
Figure 12. Global HIV Diagnostics Revenue Share by Manufacturers in 2023
Figure 13. HIV Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market HIV Diagnostics Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by HIV Diagnostics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global HIV Diagnostics Market Share by Type
Figure 18. Sales Market Share of HIV Diagnostics by Type (2019-2024)
Figure 19. Sales Market Share of HIV Diagnostics by Type in 2023
Figure 20. Market Size Share of HIV Diagnostics by Type (2019-2024)
Figure 21. Market Size Market Share of HIV Diagnostics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global HIV Diagnostics Market Share by Application
Figure 24. Global HIV Diagnostics Sales Market Share by Application (2019-2024)
Figure 25. Global HIV Diagnostics Sales Market Share by Application in 2023
Figure 26. Global HIV Diagnostics Market Share by Application (2019-2024)
Figure 27. Global HIV Diagnostics Market Share by Application in 2023
Figure 28. Global HIV Diagnostics Sales Growth Rate by Application (2019-2024)
Figure 29. Global HIV Diagnostics Sales Market Share by Region (2019-2024)
Figure 30. North America HIV Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America HIV Diagnostics Sales Market Share by Country in 2023
Figure 32. U.S. HIV Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada HIV Diagnostics Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico HIV Diagnostics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe HIV Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe HIV Diagnostics Sales Market Share by Country in 2023
Figure 37. Germany HIV Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France HIV Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. HIV Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy HIV Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia HIV Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific HIV Diagnostics Sales and Growth Rate (K Units)
Figure 43. Asia Pacific HIV Diagnostics Sales Market Share by Region in 2023
Figure 44. China HIV Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan HIV Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea HIV Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India HIV Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia HIV Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America HIV Diagnostics Sales and Growth Rate (K Units)
Figure 50. South America HIV Diagnostics Sales Market Share by Country in 2023
Figure 51. Brazil HIV Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina HIV Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia HIV Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa HIV Diagnostics Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa HIV Diagnostics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia HIV Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE HIV Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt HIV Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria HIV Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa HIV Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global HIV Diagnostics Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global HIV Diagnostics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global HIV Diagnostics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global HIV Diagnostics Market Share Forecast by Type (2025-2030)
Figure 65. Global HIV Diagnostics Sales Forecast by Application (2025-2030)
Figure 66. Global HIV Diagnostics Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of HIV Diagnostics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global HIV Diagnostics Market Size (M USD), 2019-2030
Figure 5. Global HIV Diagnostics Market Size (M USD) (2019-2030)
Figure 6. Global HIV Diagnostics Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. HIV Diagnostics Market Size by Country (M USD)
Figure 11. HIV Diagnostics Sales Share by Manufacturers in 2023
Figure 12. Global HIV Diagnostics Revenue Share by Manufacturers in 2023
Figure 13. HIV Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market HIV Diagnostics Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by HIV Diagnostics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global HIV Diagnostics Market Share by Type
Figure 18. Sales Market Share of HIV Diagnostics by Type (2019-2024)
Figure 19. Sales Market Share of HIV Diagnostics by Type in 2023
Figure 20. Market Size Share of HIV Diagnostics by Type (2019-2024)
Figure 21. Market Size Market Share of HIV Diagnostics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global HIV Diagnostics Market Share by Application
Figure 24. Global HIV Diagnostics Sales Market Share by Application (2019-2024)
Figure 25. Global HIV Diagnostics Sales Market Share by Application in 2023
Figure 26. Global HIV Diagnostics Market Share by Application (2019-2024)
Figure 27. Global HIV Diagnostics Market Share by Application in 2023
Figure 28. Global HIV Diagnostics Sales Growth Rate by Application (2019-2024)
Figure 29. Global HIV Diagnostics Sales Market Share by Region (2019-2024)
Figure 30. North America HIV Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America HIV Diagnostics Sales Market Share by Country in 2023
Figure 32. U.S. HIV Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada HIV Diagnostics Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico HIV Diagnostics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe HIV Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe HIV Diagnostics Sales Market Share by Country in 2023
Figure 37. Germany HIV Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France HIV Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. HIV Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy HIV Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia HIV Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific HIV Diagnostics Sales and Growth Rate (K Units)
Figure 43. Asia Pacific HIV Diagnostics Sales Market Share by Region in 2023
Figure 44. China HIV Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan HIV Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea HIV Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India HIV Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia HIV Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America HIV Diagnostics Sales and Growth Rate (K Units)
Figure 50. South America HIV Diagnostics Sales Market Share by Country in 2023
Figure 51. Brazil HIV Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina HIV Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia HIV Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa HIV Diagnostics Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa HIV Diagnostics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia HIV Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE HIV Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt HIV Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria HIV Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa HIV Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global HIV Diagnostics Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global HIV Diagnostics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global HIV Diagnostics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global HIV Diagnostics Market Share Forecast by Type (2025-2030)
Figure 65. Global HIV Diagnostics Sales Forecast by Application (2025-2030)
Figure 66. Global HIV Diagnostics Market Share Forecast by Application (2025-2030)
